← Back to Search

BinaxNOW Test for COVID-19

N/A
Waitlist Available
Led By Ellen R Wald, MD
Research Sponsored by University of Wisconsin, Madison
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
have at least one symptom of COVID-19
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 24 hours
Awards & highlights

Study Summary

This trial will test whether BinaxNOW testing is non-inferior to PCR testing for children and adults in the Madison Metropolitan School District.

Eligible Conditions
  • COVID-19
  • Coronavirus

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You have at least one symptom of COVID-19.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 24 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 24 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Negative Predictive Value (NPV) of BinaxNOW
Number of successfully completed at-home tests
Percent of participants who answer 'yes' when asked if lollipop swabs are more acceptable than nasal swabs
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: BinaxNOW Test + Lollipop PCRExperimental Treatment2 Interventions
If a symptomatic participant's initial at-school BinaxNOW test was positive, then their study participation is complete after providing the lollipop swab for PCR testing. If a symptomatic participant's initial at-school BinaxNOW test was negative, then they will be asked to complete an at-home BinaxNOW test approximately 24 hours later. For the at-home BinaxNOW testing, the participant will schedule a follow-up virtual visit with the study coordinator. If they are unable to complete a virtual visit, they will schedule an in-person home visit. They will also be sent home with a BinaxNOW testing kit.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
BinaxNOW Test
2021
N/A
~100
"Lollipop" swab
2021
N/A
~100

Find a Location

Who is running the clinical trial?

University of Wisconsin, MadisonLead Sponsor
1,177 Previous Clinical Trials
3,012,054 Total Patients Enrolled
14 Trials studying COVID-19
1,667,105 Patients Enrolled for COVID-19
Ellen R Wald, MDPrincipal InvestigatorUniversity of Wisconsin, Madison
10 Previous Clinical Trials
2,868 Total Patients Enrolled
1 Trials studying COVID-19
65 Patients Enrolled for COVID-19

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~29 spots leftby Mar 2025